Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaoliang Su

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Journal of Leukocyte Biology|November 29, 2021
ErratumZhaoliang Su
Immunology|September 23, 2020
Friend or foe of innate lymphoid cells in inflammation-associated cardiovascular diseaseXiangmei Gong, Lin Xia, Zhaoliang Su
Signal Transduction and Targeted Therapy|October 26, 2023
Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer controlJian Chen, Zhaoliang Su, Guangchuan Wang
International Immunopharmacology|February 17, 2020
Effects of IL-22 on cardiovascular diseasesYang Che, Zhaoliang Su, Lin Xia
Cellular and Molecular Neurobiology|November 19, 2021
HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's DiseaseYu Tian, Rong Chen, Zhaoliang Su
Immunologic Research|January 23, 2021
Effects of functionally diverse calpain system on immune cellsYueqi Chen, Zhaoliang Su, Fang Liu
Yonsei Medical Journal|August 28, 2007
Avian influenza: should China be alarmed?Zhaoliang Su, Huaxi Xu, Jianguo Chen
International Immunopharmacology|February 15, 2020
Crosstalk among colon cancer-derived exosomes, fibroblast-derived exosomes, and macrophage phenotypes in colon cancer metastasisMeiyun Wang, Zhaoliang Su, Prince Amoah Barnie
International Immunopharmacology|December 28, 2019
The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targetsHongxia Wu, Zhaoliang Su, Prince Amoah Barnie
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|September 27, 2016
[Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro]Zhaoliang Su, Yongjian Zhang, Ping Ni, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Journal of Leukocyte Biology|November 29, 2021
ErratumZhaoliang Su
Immunology|September 23, 2020
Friend or foe of innate lymphoid cells in inflammation-associated cardiovascular diseaseXiangmei Gong, Lin Xia, Zhaoliang Su
Signal Transduction and Targeted Therapy|October 26, 2023
Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer controlJian Chen, Zhaoliang Su, Guangchuan Wang
International Immunopharmacology|February 17, 2020
Effects of IL-22 on cardiovascular diseasesYang Che, Zhaoliang Su, Lin Xia
Cellular and Molecular Neurobiology|November 19, 2021
HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's DiseaseYu Tian, Rong Chen, Zhaoliang Su
Immunologic Research|January 23, 2021
Effects of functionally diverse calpain system on immune cellsYueqi Chen, Zhaoliang Su, Fang Liu
Yonsei Medical Journal|August 28, 2007
Avian influenza: should China be alarmed?Zhaoliang Su, Huaxi Xu, Jianguo Chen
International Immunopharmacology|February 15, 2020
Crosstalk among colon cancer-derived exosomes, fibroblast-derived exosomes, and macrophage phenotypes in colon cancer metastasisMeiyun Wang, Zhaoliang Su, Prince Amoah Barnie
International Immunopharmacology|December 28, 2019
The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targetsHongxia Wu, Zhaoliang Su, Prince Amoah Barnie
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|September 27, 2016
[Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro]Zhaoliang Su, Yongjian Zhang, Ping Ni, et al.
Pageof 15